| Announce Date | 10/27/2025 |
| EPS Normalized Actual | $0.1132 (Miss by $-0.1268) |
| EPS GAAP Actual | $0.1132 (Miss by $-0.1268) |
| Revenue Actual | $2.176B |
| Revenue Surprise | Beat by $2176M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 2.29 | 6.76 | 2.20891 | 2.3537 | 2 |
| Dec 2027 | 2.21 | 7 | 2.13174 | 2.27147 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.11 | 0.11 | 2.176B | -0.69% | 2176M |
| FQ2 2025 (Jun 2025) | 0.29 | 0.29 | 2.188B | -1.28% | 2188M |
| FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 2.103B | -2.47% | 2103M |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 2.308B | -1.52% | 2308M |
| FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 2.191B | 0.27% | 2191M |
| FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 2.216B | 5.55% | 2216M |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 2.155B | 8.96% | 2155M |
| FQ4 2023 (Dec 2023) | 1.52 | 1.52 | 2.343B | 11.52% | 2343M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0.4228 | -- | 0.41125 | 0.4303 | 10 |
| FQ3 2029 (Sep 2029) | 0.5601 | -- | 0.54021 | 0.61919 | 9 |
| FQ2 2029 (Jun 2029) | 0.54 | -- | 0.52083 | 0.59697 | 6 |
| FQ1 2029 (Mar 2029) | 0.5048 | -- | 0.48688 | 0.55806 | 4 |
| FQ4 2028 (Oct 2028) | 0.5362 | -- | 0.5362 | 0.5362 | 15 |
| FQ3 2028 (Jul 2028) | 0.5119 | -- | 0.5119 | 0.5119 | 8 |
| FQ2 2028 (Jun 2028) | 0.5119 | -- | 0.49047 | 0.52424 | 8 |
| FQ1 2028 (Mar 2028) | 0.4854 | -- | 0.46508 | 0.4971 | 9 |
| FQ4 2027 (Oct 2027) | 0.5085 | -- | 0.5085 | 0.5085 | 10 |
| FQ3 2027 (Jul 2027) | 0.4861 | -- | 0.4861 | 0.4861 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 3.49B | -- | 3.41B | 3.53B | 14 |
| FQ3 2029 (Sep 2029) | 2.54B | -- | 2.47B | 2.75B | 9 |
| FQ2 2029 (Jun 2029) | 2.53B | -- | 2.46B | 2.73B | 8 |
| FQ1 2029 (Mar 2029) | 2.51B | -- | 2.44B | 2.71B | 7 |
| FQ4 2028 (Oct 2028) | 2.46B | -- | 2.46B | 2.46B | 5 |
| FQ3 2028 (Jul 2028) | 2.44B | -- | 2.44B | 2.44B | 5 |
| FQ2 2028 (Jun 2028) | 2.49B | -- | 2.41B | 2.54B | 5 |
| FQ1 2028 (Mar 2028) | 2.48B | -- | 2.4B | 2.52B | 5 |
| FQ4 2027 (Oct 2027) | 2.39B | -- | 2.39B | 2.39B | 6 |
| FQ3 2027 (Jul 2027) | 2.37B | -- | 2.37B | 2.37B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.11 | 0.11 | 100% | |
| FQ2 2025 (Jun 2025) | 0.29 | 0.29 | 100% | |
| FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 100% | |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
| FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 100% | |
| FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 100% | |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 100% | |
| FQ4 2023 (Dec 2023) | 1.52 | 1.52 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2.18B | $2176M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.19B | $2188M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.1B | $2103M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.31B | $2308M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.19B | $2191M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.22B | $2216M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.16B | $2155M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.34B | $2343M | 100% |